.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advancements in CLL Treatment: Optimizing Outcomes with Novel Therapeutics and Strategies

EP. 1: Dr Jain on Treatment Considerations in the Frontline Management of CLL

October 9th 2024

Nitin Jain, MD, discusses current treatment options and considerations for the frontline management of CLL.

EP. 2: BTK Inhibitors vs Venetoclax: Considerations for Frontline Treatment Selection in CLL

October 14th 2024

Nitin Jain, MD, discusses the use of BTK inhibitor– and venetoclax-based regimens for the frontline treatment of chronic lymphocytic leukemia.

Advancements in CLL Treatment: Optimizing Outcomes with Novel Therapeutics and Strategies​

EP. 1: Dr Jain on Treatment Considerations in the Frontline Management of CLL

EP. 2: BTK Inhibitors vs Venetoclax: Considerations for Frontline Treatment Selection in CLL

Advancements in CLL Treatment: Optimizing Outcomes with Novel Therapeutics and Strategies